Literature DB >> 9112238

The toxic oil syndrome: an example of an exogenously induced autoimmune reaction. Toxic oil syndrome.

S A Bell1.   

Abstract

The toxic oil syndrome (TOS) is a chemically induced autoimmune-like reaction in humans. The etiologic agent(s) have so far not clearly been identified. A short overview is given on this disease which is associated with a unique antibody specificity to cryptic epitopes of C-reactive protein in affected patients. In addition a murine model for TOS is described which suggests that genetic susceptibility might play a role in inducing a similar syndrome in mice. These differences are reflected in the immunological alterations and cytokine production caused by the toxicant.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9112238     DOI: 10.1007/bf00351178

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  15 in total

1.  Chemical correlates of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.

Authors:  E M Kilbourne; J T Bernert; M Posada de la Paz; R H Hill; I Abaitua Borda; B W Kilbourne; M M Zack
Journal:  Am J Epidemiol       Date:  1988-06       Impact factor: 4.897

2.  Expression, detection and assay of a neoantigen (Neo-CRP) associated with a free, human C-reactive protein subunit.

Authors:  L A Potempa; J N Siegel; B A Fiedel; R T Potempa; H Gewurz
Journal:  Mol Immunol       Date:  1987-05       Impact factor: 4.407

3.  Isotype-restricted hyperimmunity in a murine model of the toxic oil syndrome.

Authors:  S A Bell; M V Hobbs; R L Rubin
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

4.  Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline.

Authors:  J M Tabuenca
Journal:  Lancet       Date:  1981-09-12       Impact factor: 79.321

5.  Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils.

Authors:  X Jiang; G Khursigara; R L Rubin
Journal:  Science       Date:  1994-11-04       Impact factor: 47.728

6.  Autoantibodies to cryptic epitopes of C-reactive protein and other acute phase proteins in the toxic oil syndrome.

Authors:  S A Bell; T W Du Clos; G Khursigara; J J Picazo; R L Rubin
Journal:  J Autoimmun       Date:  1995-04       Impact factor: 7.094

7.  Chronicity of the eosinophilia-myalgia syndrome. A reassessment after three years.

Authors:  L D Kaufman
Journal:  Arthritis Rheum       Date:  1994-01

8.  Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome.

Authors:  A N Mayeno; L M Benson; S Naylor; M Colberg-Beers; J T Puchalski; G J Gleich
Journal:  Chem Res Toxicol       Date:  1995 Oct-Nov       Impact factor: 3.739

9.  Toxic oil syndrome. A long-term follow-up of a cohort of 332 patients.

Authors:  A Alonso-Ruiz; M Calabozo; F Perez-Ruiz; L Mancebo
Journal:  Medicine (Baltimore)       Date:  1993-09       Impact factor: 1.889

Review 10.  Toxic oil syndrome and eosinophilia-myalgia syndrome: May 8-10, 1991, World Health Organization meeting report.

Authors:  R M Philen; M Posada
Journal:  Semin Arthritis Rheum       Date:  1993-10       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.